approved

Sirtex Medical’s SIR-Spheres Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma

Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma…

5 months ago

VivoPower Commences $29 Million Shareholder Loan Financing Retirement Plan

LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) (“VivoPower” or the “Company”) announced today that its…

5 months ago

Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of…

6 months ago

Avricore Grants Options

June 14, 2025 01:05 ET  | Source: Avricore Health Inc. VANCOUVER, British Columbia, June 14, 2025 (GLOBE NEWSWIRE) -- AVRICORE…

6 months ago

JZXN Raises Funds through Convertible Notes to Acquire Bitcoin, Initiating a Strategic Layout of Thousands of Bitcoins

HANGZHOU, China, June 11, 2025 /PRNewswire/ -- JZXN Holdings, Inc. (NASDAQ: JZXN; the "Company") announced that its board of directors has…

6 months ago

Ski Jumping: yellow and red card sanctions among changes to be introduced for equipmentrelated infractions in 2025/26

Jun 13, 2025 - Having reviewed a set of proposals by the Ski Jumping Sub-Committee for Equipment and Development during its…

6 months ago

BingX Listed as Approved VASP by Upbit Korea Under Travel Rule Framework

PANAMA CITY, June 13, 2025 /PRNewswire/ -- BingX, a leading cryptocurrency exchange and Web3 AI company, announced it has been officially…

6 months ago

Orezone Announces Results of Meeting of Shareholders

VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”)…

6 months ago

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

June 11, 2025 11:30 ET  | Source: Onconetix, Inc. CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ:…

6 months ago

European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy

MILAN, Italy, June 06, 2025 – Italfarmaco S.p.A. announced today that the European Commission (EC) has granted conditional marketing authorisation…

6 months ago